Toxoplasma gondii: decreased resistance to infection in mice due to estrogen.
Exposure to pharmacological concentrations of potent estrogenic compounds, including 17 beta-estradiol, diethylstilbestrol, and alpha-dienestrol, increased the susceptibility of mice to Toxoplasma gondii as measured by brain cyst formation. Compounds with weak estrogenic activity or other hormonal activity, including 5 alpha-dihydrotestosterone, progesterone, and zearalanol, did not alter host resistance to infection. The ability of estrogens to alter susceptibility was inhibited by the estrogen antagonist, tamoxifen. The restoration of ovariectomized mice with normal physiological concentrations of estrogen had no effect on subsequent infection with T. gondii. These results indicate that pharmacological, but not physiological, levels of estrogen selectively alter host resistance to T. gondii, possibly through hormonal events.
D000818:Animals; D004028:Dienestrol / Q000494:pharmacology; D004054:Diethylstilbestrol / Q000494:pharmacology*; D004958:Estradiol / Q000031:analogs & derivatives / Q000097:blood / Q000494:pharmacology*; D005260:Female; D007113:Immunity, Innate / Q000187:drug effects; D051379:Mice; D010052:Ovariectomy; D013629:Tamoxifen / Q000494:pharmacology; D014124:Toxoplasmosis, Animal / Q000276:immunology*
D013629:Tamoxifen; D004958:Estradiol; D004054:Diethylstilbestrol; C007630:estradiol 17 beta-cypionate; D004028:Dienestrol